The agreement lets manufacturers pair 3M's Harvest RC Chromatographic Clarifier, a single-stage purification solution, with Thermo Fisher Scientific's HyPerforma Single-Use Bioreactor systems. The combination of these two technologies can bring greater efficiency and scalability to the therapeutic manufacturing process, company leaders said.

Additional details, including the commercial availability of products associated with the collaboration, will be announced in the coming months, the companies said.

Thermo Fisher reports revenue boost in Q3
Thermo Fisher Scientific reported a 9% increase in revenue for the third quarter of 2021, although its net income slipped slightly. The company saw its...

Thermo Fisher unveils new NK cell culture medium
Thermo Fisher Scientific has introduced Gibco Cell Therapy Systems NK-Xpander Medium, a new cell culture medium that supports the large-scale growth and...

Thermo Fisher opening new biologics site in Switzerland
Thermo Fisher Scientific recently assumed operational responsibility for a new biologics manufacturing site in Lengnau, Switzerland, the company announced.

Thermo Fisher seeks grant proposals that leverage NGS
Thermo Fisher Scientific is accepting new proposals that leverage next-generation sequencing (NGS) for its Oncomine Clinical Research Grant.

3M launches new chromatography solution for biomanufacturing
3M Health Care has launched its 3M Polisher ST product, a single-use anion exchange chromatography solution designed to replace reusable polishing columns...